Business Context and Reporting Period
Company: Home BancShares, Inc. (HOMB)
Filing Type: Form 8-K (Current Report)
Date of Report: April 1, 2026
Event: Completion of the previously announced acquisition of Mountain Commerce Bancorp, Inc. ("MCBI").
Key Financial Metrics and Transaction Details
- Consideration Type: Stock-for-stock merger with no cash consideration, except for fractional shares.
- Shares Issued: Approximately 5.4 million shares of Home BancShares common stock.
- Transaction Value: Approximately $146 million (valued as of April 1, 2026).
- Exchange Ratio: 0.85 shares of Home BancShares common stock for each share of MCBI common stock.
- Fractional Share Payment: Cash paid at a rate of $26.77 per fractional share.
Material Changes and Merger Structure
Effective April 1, 2026, the following corporate actions were completed pursuant to the Merger Agreement dated December 7, 2025:
- HOMB Acquisition Sub IV, Inc. merged with and into MCBI.
- MCBI merged with and into Home BancShares, Inc., with Home BancShares as the surviving entity.
- Mountain Commerce Bank merged with and into Centennial Bank (Home's subsidiary), with Centennial Bank as the surviving entity.
Guidance, Outlook, and Risks
The filing does not provide specific forward-looking guidance, financial projections, or risk factors related to the post-merger outlook. The document notes that the information furnished in Item 7.01 and the attached press release is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the exact number of shares issued and the final transaction value in the attached press release (Exhibit 99.1).
- Confirm the impact of the 5.4 million new shares on Home BancShares' total outstanding share count and earnings per share (EPS) dilution.
- Review the Merger Agreement (Exhibit 2.1) for any contingent liabilities or earn-out provisions not detailed in this summary.
- Assess the integration timeline and expected synergies as detailed in the press release.